■该研究旨在评估无并发症尿路感染(UTI)病例的经验性抗生素处方,并将其与印度医学研究委员会(ICMR)2017年抗菌药物使用指南进行比较。这项研究的目的是研究与ICMR推荐的指南相关的简单UTI处方的依从性,并根据达到症状缓解的平均天数评估成功率。
■这项研究是针对泌尿外科就诊的患者(年龄>16岁)进行的,医学和妇科OPD在两个月内抱怨不复杂的UTI。使用描述性统计来评估结果。
■共纳入115例UTI患者,并对其症状缓解进行随访。67例(58.26%)患者服用抗生素,首选的是左氧氟沙星500毫克O.D.在24(35.82%),呋喃妥因100mgB.D.21例(31.34%),左氧氟沙星750mgO.D.6例(8.95%),平均持续时间分别为7.83±2.37、7.52±2.68和4.33±1.03天。6例(25%)出现症状缓解,5±0.63天内15例(71.42%),4例(66.67%),4.2±2.11天和4.5±1天,分别。
■23(34.32%)基于经验性抗生素选择的处方和17(25.37%)基于抗生素选择和治疗持续时间的处方均符合(ICMR)-2017指南。结果表明,复方新诺明和环丙沙星作为经验性治疗急性单纯性UTI的疗效降低。
UNASSIGNED: The study was undertaken to assess the empirical antibiotic prescription in uncomplicated urinary tract infection (UTI) cases and compare them with the Indian council of medical research (ICMR) 2017
guidelines on antimicrobial use. The objective of this study was to study the compliance of prescriptions for uncomplicated UTI with respect to the
guidelines recommended by ICMR and assess the success rates in terms of mean days taken to achieve symptomatic relief.
UNASSIGNED: This study was conducted on patients (of age >16 years) presenting to the Urology, Medicine and Gynecology OPD with complaints of uncomplicated UTI over two months. Descriptive statistics were used to assess the results.
UNASSIGNED: A total of 115 UTI patients were enrolled and followed up for symptomatic relief. 67 (58.26%) patients were prescribed antibiotics, the preferred ones were levofloxacin 500 mg O.D. in 24 (35.82%), nitrofurantoin 100 mg B.D. in 21 (31.34%) and levofloxacin 750 mg O.D. in 6 (8.95%) patients for a mean duration of 7.83 ± 2.37, 7.52 ± 2.68 and 4.33 ± 1.03 days respectively. Symptomatic relief was seen in 6 (25%), 15 (71.42%) and 4 (66.67%) cases within 5 ± 0.63 days, 4.2 ± 2.11 days and 4.5 ± 1 days, respectively.
UNASSIGNED: 23 (34.32%) prescriptions based on choice of empirical antibiotic and 17 (25.37%) prescriptions based on both choice of antibiotic and duration of therapy were found to be compliant with the (ICMR) -2017
guidelines. Results show decreased efficacy of co-trimoxazole and ciprofloxacin as empirical therapy for acute uncomplicated UTI.